IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Advanced Enzyme Technologies IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 411.49 Cr. The company is based in Mumbai and caters to Healthcare sector. Axis Capital , ICICI Securities are the merchant bankers of Advanced Enzyme Technologies IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th January 2016.
Advanced Enzyme Technologies IPO open date is 20th July 2016 and close date is 22nd July 2016. IPO Allotment Date is 30th November -0001 and Listing date is 1st August 2016.
IPO
Size:
₹ 411.49 Cr.
Avg IPO Size (Sector Based)
: ₹
978.00 cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹
78.44
cr. 
PE
Ratio:
25.00x
Average Sector PE Ratio: 27.92x
Advanced Enzyme Technologies IPO size is ₹ 411.49 Cr. with IPO price of ₹ 896.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Advanced Enzyme Technologies IPO. Link Intime India Private Limited is the Registrar for Advanced Enzyme Technologies IPO.
Advanced Enzyme Technologies IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Advanced Enzyme Technologies IPO, based in Mumbai, operates in the Healthcare sector with a focus on research and development manufacturing and marketing of healthcare products. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Advanced Enzyme Technologies IPO size is ₹ 411.49 Cr. with fresh issue size of ₹ 411 and Offer for sale being ₹ Nil
The IPO allotment date for Advanced Enzyme Technologies IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Advanced Enzyme Technologies IPO allotment status on the registrars website, Link Intime India Private Limited . Advanced Enzyme Technologies IPO refund dates are 30th November -0001.
Advanced Enzyme Technologies IPO is expected to be listed on 1st August 2016.
The upper price band for the Advanced Enzyme Technologies IPO is set at ₹ 896.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Advanced Enzyme Technologies IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Advanced Enzyme Technologies IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 22nd July 2016. After submission, funds are blocked until the basis of allotment of Advanced Enzyme Technologies IPO is finalised.
The merchant banker for Advanced Enzyme Technologies IPO is Axis Capital Limited , ICICI Securities Limited . Axis Capital Limited , ICICI Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Advanced Enzyme Technologies IPO RHP for further details.
The registrar for Advanced Enzyme Technologies IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Advanced Enzyme Technologies IPO through their official website or helpline.
Advanced Enzyme Technologies IPO was subscribed 116.02 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 411.49 Cr.
Avg IPO Size (Sector Based)
:
₹ 978.00 Cr.
Sector: Healthcare
IPO so far:
28
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹ 294.63 cr.
PE
Ratio:
25.00x
Average Sector PE Ratio: 27.92x
Advanced Enzyme Technologies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Advanced Enzyme Technologies Financial Review Page
Merchant Banker(s) of Advanced Enzyme Technologies IPO: Axis Capital Limited , ICICI Securities Limited
Advanced Enzyme Technologies IPO subscription was 116.02 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Advanced Enzyme Technologies IPO listed at a listing price of 1178.30 against the offer price of 896.00.
The current market price of Advanced Enzyme Technologies is 324.45.
Why Us?
